Associations of plasma sphingolipid profiles with insulin response during oral glucose testing in Icelandic horses.

Summary

# Editorial Summary Sphingolipids, particularly ceramides, have been shown to regulate insulin sensitivity in multiple mammalian species, yet their role in equine metabolic dysfunction remains poorly characterised. This 2021 investigation examined whether plasma sphingolipid profiles could be associated with insulin response patterns during oral glucose tolerance testing in Icelandic horses, a breed predisposed to insulin dysregulation and equine metabolic syndrome. The researchers measured ceramide and related sphingolipid concentrations alongside dynamic insulin responses following glucose administration, seeking to establish whether alterations in sphingolipid metabolism could serve as biomarkers or mechanistic indicators of impaired insulin sensitivity in horses. Understanding these lipid-mediated pathways has direct implications for identifying at-risk individuals earlier and potentially developing targeted nutritional or pharmaceutical interventions, given that ceramide accumulation in peripheral tissues is mechanistically linked to insulin resistance development in other species. For practitioners managing metabolically compromised horses—particularly breeding stock or those with recurrent laminitis—these findings could inform metabolic profiling protocols beyond conventional measurements of basal insulin and glucose.

Read the full abstract on PubMed

Key Findings

• •Plasma sphingolipid profiles are associated with insulin response during oral glucose testing in horses
• •Ceramide synthesis is linked to decreased insulin sensitivity, consistent with mammalian models
• •Insulin signaling pathway activation downregulates ceramide synthesis in equine metabolism

Conditions Studied

Tags